Undiagnosed Coronary Artery Disease in Hemodialysis-Initiating Patients

Hirohito Sugawara1, Kiryu Yoshida1, Hiroya Shigematsu1

  • 1Division of Nephrology, Department of Internal Medicine, Showa Medical University Northern Yokohama Hospital.

Insights

Undiagnosed coronary artery disease (CAD) affects nearly half of patients starting hemodialysis. Smoking history, statin use, and low albumin/HDL-C levels were linked to CAD in this end-stage renal disease population.

Area of Science:

  • Cardiology
  • Nephrology
  • Radiology

Background:

  • End-stage renal disease (ESRD) patients on hemodialysis have a high risk of cardiovascular disease.
  • Undiagnosed coronary artery disease (CAD) is a significant concern in this population.
  • Understanding CAD prevalence and risk factors is crucial for patient management.

Purpose of the Study:

  • To update the understanding of undiagnosed CAD in Japanese patients initiating hemodialysis.
  • To investigate CAD prevalence, associated risk factors, and coronary lesion distribution.
  • To analyze temporal trends in CAD prevalence and coronary artery calcification scores (CACS).

Main Methods:

  • Retrospective cross-sectional study of 272 patients undergoing hemodialysis for ESRD between 2009-2023.
  • Coronary computed tomography (CCT) used for initial screening and confirmation (with coronary angiography/CAG).
  • Logistic regression analysis identified factors associated with CAD; temporal trends in CACS and prevalence were assessed.

Main Results:

  • CAD was present in 47% of patients, with lesions predominantly in the left anterior descending artery (73%).
  • Coronary artery calcification score (CACS) >65 increased from 2012-2014 to 2015-2017, then stabilized.
  • Smoking history, statin use, low albumin, and low HDL-C were independently associated with CAD.

Conclusions:

  • Traditional CAD risk factors seen in the general population were not significant predictors in this ESRD cohort.
  • This highlights unique pathophysiological mechanisms of CAD in patients undergoing hemodialysis.
  • Further research is needed to identify specific risk factors and improve screening strategies.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
311
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
148
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
87